Direxion Daily CSI China Internet Index Bull 2X Shares

Most Recent

  • uploads///AdobeStock_
    Cannabis

    The Pet Cannabis Industry Is a Lucrative Opportunity

    Spending on pet care is gradually rising in the US. As reported by CNBC, Nielsen estimated Americans spent $33 billion on pet food and treats last year.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    Is Charlotte’s Web Holdings a Good Buy This Month?

    Charlotte’s Web Holdings (CWEB) (CWBHF) stock is currently down 23.64% year-to-date on US over-the-counter exchanges. What’s affected investor sentiment?

    By Margaret Patrick
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///AdobeStock_
    Cannabis

    What’s the Market Potential for CBD?

    The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

    By Margaret Patrick
  • uploads///cresco labs
    Cannabis

    Why Origin House’s Acquisition Is Vital for Cresco Labs

    On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.

    By Rajiv Nanjapla
  • uploads///canopy_
    Cannabis

    What’s Canopy Growth’s First & Free Brand About?

    Yesterday, BNB Bloomberg reported that Canopy Growth (CGC) (WEED) had officially entered the US CBD market with its First & Free brand.

    By Rajiv Nanjapla
  • uploads///curaleaf new jersey
    Cannabis

    Curaleaf Holdings Completes Curaleaf NJ’s Acquisition

    Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

    By Rajiv Nanjapla
  • uploads///dea
    Cannabis

    Analyzing the Top 3 CBD Companies to Buy in July

    Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand

    Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

    By Rajiv Nanjapla
  • uploads///charlottes web abacus health
    Cannabis

    Will the Abacus Health Acquisition Benefit Charlotte’s Web?

    On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.

    By Sushree Mohanty
  • uploads///Curaleaf
    Cannabis

    Curaleaf: Analysts’ Recommendations after Its Q1 Earnings

    Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Why Did Curaleaf Report a Mixed Q1 Performance?

    On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

    By Rajiv Nanjapla
  • uploads///green thumb industries
    Cannabis

    Green Thumb Industries Had a Good Start to Fiscal 2020

    Green Thumb Industries reported impressive results for the first quarter of fiscal 2020 on Thursday after the market closed.

    By Sushree Mohanty
  • uploads///cweb_
    Cannabis

    Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

    Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Charlotte’s Web Reports Mixed Q1 Performance

    Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

    By Rajiv Nanjapla
  • uploads///charlottes web upcoming earnings
    Cannabis

    Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings

    Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

    By Rajiv Nanjapla
  • uploads///CWEB_
    Cannabis

    Analysts’ Recommendations after Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings reported its fourth-quarter earnings on March 24. For the quarter, the company missed analysts’ revenue and EBITDA estimates.

    By Rajiv Nanjapla
  • uploads///CWEB_
    Cannabis

    What to Expect from Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.

    By Rajiv Nanjapla
  • uploads///supreme cannabis analysts hold rating
    Cannabis

    What Do Analysts Recommend for Supreme Cannabis?

    Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’

    By Rajiv Nanjapla
  • uploads///Green Growth
    Cannabis

    Charlotte’s Web Reports Improved Yield and CBD Potency

    On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

    By Rajiv Nanjapla
  • uploads///curaleaf bluekudu
    Cannabis

    How Will Curaleaf Benefit from Acquiring BlueKudu?

    On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

    By Rajiv Nanjapla
  • uploads///green growth brands upcoming earnings
    Cannabis

    What to Expect from Green Growth Brands’ Q2 Earnings?

    Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.

    By Rajiv Nanjapla
  • uploads///APHA_
    Cannabis

    Has Cresco Labs Bottomed Out in 2020?

    As of Tuesday, Cresco Labs was trading at 6.73 Canadian dollars, which represents a fall of 24.6% since the beginning of the year.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Beacon Securities Is Still Bullish on Curaleaf

    After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.

    By Rajiv Nanjapla
  • uploads///iipr and gti
    Cannabis

    IIPR Enters a Long-Term Agreement with GTI

    Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.

    By Rajiv Nanjapla
  • uploads///hemp
    Cannabis

    Idaho Introduces Bill to Legalize Hemp

    Despite federal legalization, Idaho hasn’t legalized hemp. However, Idaho’s House passed a bill that would allow hemp to be transported through the state.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Cresco Labs Stock Rose after Securing $100 Million Loan

    On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Is Cresco Labs a Good Bet in January?

    Analysts expect Cresco Labs to report revenues of $45.3 million in the fourth quarter to take the total revenue for 2019 to $131.9 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Is Charlotte’s Web Still a Good Buy?

    Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.

    By Rajiv Nanjapla
  • uploads///GGB_
    Cannabis

    Green Growth Brands: Analysts’ Ratings and Target Price

    Analysts expect Green Growth to become profitable in fiscal 2021. In fiscal 2020, they expect the company to report a negative EBITDA of $80.2 million.

    By Rajiv Nanjapla
  • uploads///cbd new bill
    Cannabis

    Will the New CBD Bill Boost US Businesses?

    For CBD products, federal regulation could take years. However, the situation might change with the introduction of Collin Peterson’s new bill.

    By Rajiv Nanjapla
  • uploads///TerrAscend
    Cannabis

    TerrAscend Private Placement Oversubscribed

    TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Has Supreme Cannabis’s Stock Price Bottomed Out?

    As of December 24, Supreme Cannabis was trading at 0.66 Canadian dollars. The company has lost 50% of its stock value this year. Has its stock bottomed out?

    By Rajiv Nanjapla
  • uploads///Fire
    Cannabis

    Supreme Cannabis: Lower Target Price after Q1 Earnings

    Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Charlotte’s Web Lawsuit: How Can It Impact Investors?

    Charlotte’s Web Holdings (CWEB) (CWBHF) is one of the latest cannabis companies to be served with a class-action lawsuit.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    Is Jim Cramer Not a Fan of Cannabis Stocks Anymore?

    Jim Cramer expressed disappointment with the cannabis industry, claiming it may not be the “incredible opportunity” he thought it was.

    By Margaret Patrick
  • uploads///Roku Q reve growth
    Cannabis

    Charlotte’s Web: An Overview of a Cannabis Giant

    Charlotte’s Web Holdings, Inc. (CWEB) is a US-based vertically integrated CBD producer. The company focuses on making and distributing hemp-derived CBD products. Charlotte’s Web’s mission is to help people find peace in mind, body, and soul. Further, the company aims to meet the consumer’s demands for quality products, efficiency, and consistency. Initial development Charlotte’s Web […]

    By Nivedha Elango
  • uploads///AdobeStock_
    Cannabis

    Must-Knows of Fraud Investigations into ACB and CGC

    Several prominent law firms have launched investigations into ACB and CGC for potentially violating federal securities law.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    ACB Sees Third-Worst Day in Years: What Analysts Think

    On November 18, Aurora Cannabis (ACB) closed at 3 Canadian dollars on the TSX, a 16.43% drop and the third-worst trading day for it in three years.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    MedMen Fights for Survival amid Sector Meltdown

    On November 15, MedMen (MMEN) (MMNFF) declared an extensive five-year restructuring plan in its attempt to become EBITDA-positive by 2020.

    By Margaret Patrick
  • uploads///samson ZGjbiukp_ A unsplash
    Cannabis

    Top 5 Reasons Why Cannabis Earnings Disappointed

    There seems to be no end to the cannabis sector’s woes. Several prominent cannabis players reported disappointing results in the latest earnings season.

    By Margaret Patrick
  • uploads///charlottes web
    Cannabis

    Charlotte’s Web: Analysts Cut Targets after Weak Q3

    Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    The Cannabis Sector Continues Its Disappointing Week

    After falling for the first two days this week, the cannabis sector maintained that weakness today. Let’s look at some cannabis stocks that are in the news.

    By Rajiv Nanjapla
  • uploads///CGC_
    Cannabis

    Canopy Growth Is Down ahead of Its Q2 Release

    Canopy Growth is set to report its second-quarter earnings results on November 14. In the first two days of trading this week, it’s fallen 11.5%.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Charlotte’s Web: Q3 Earnings Missed Analysts’ Estimates

    Today, Charlotte’s Web Holdings (CWEB) (CWBHF) reported its third-quarter earnings. The company missed analysts’ revenue and EPS estimates.

    By Rajiv Nanjapla
  • uploads///cweb
    Cannabis

    Charlotte’s Web: What to Expect from Q3 Earnings

    Charlotte’s Web Holdings (CWEB) (CWBHF) will report third-quarter earnings before the market opens on November 13. Let’s look at analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Charlotte’s Web: November Price Target Update

    Charlotte’s Web Holdings has fallen 15.44% on the Toronto Stock Exchange. Its stock has dropped 43.58% on the TSE since its Q2 earnings on August 14.

    By Margaret Patrick
  • uploads///IIPR
    Cannabis

    IIPR Stock Rises after Revenue and EPS Beat

    Yesterday, Innovative Industrial Properties (IIPR) reported its Q3 earnings results. The company beat analysts’ revenue and EPS estimates.

    By Rajiv Nanjapla
  • uploads///cannabis_
    Cannabis

    Can ACB’s and CWEB’s Earnings Help Cannabis?

    Aurora Cannabis and Charlotte’s Web Holdings are set to report their earnings next week. Could their results bring some relief to the cannabis sector?

    By Rajiv Nanjapla
  • uploads///curaleaf
    Cannabis

    Curaleaf Launches Adult-Use Cannabis in MA

    Yesterday, Curaleaf Holdings (CURLF) (CURA) opened its first recreational or adult-use dispensary in Massachusetts at Oxford.

    By Rajiv Nanjapla
  • uploads///CB
    Cannabis

    Charlotte’s Web: Top Four Things to Know about the Stock

    Last month, Charlotte’s Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.

    By Rajiv Nanjapla
  • uploads///CWED
    Cannabis

    Charlotte’s Web: What’s the Word on Wall Street?

    Last month, Charlotte’s Web Holdings (CWBHF) (CWEB) announced its second-quarter results. It missed analysts’ revenue and EPS expectations.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Consumer

    Charlotte’s Web Holdings Stock Down after Earnings

    Charlotte’s Web Holdings stock (CWBHF)(CWEB) was down 6.6% yesterday after the company reported lower-than-expected Q2 earning results.

    By Sushree Mohanty
  • uploads///part
    Company & Industry Overviews

    Key Cannabis Sector Updates: Analyst Ratings and Earnings

    Last week, Emerald Health Therapeutics (EMH) closed with losses of 9.4%.

    By Mohit Oberoi, CFA
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.